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Abstract
Background: Because of the increasing importance of computer-assisted post processing of image data in modern
medical diagnostic we studied the value of an algorithm for assessment of single photon emission computed
tomography/computed tomography (SPECT/CT)-data, which has been used for the first time for lymph node
staging in penile cancer with non-palpable inguinal lymph nodes. In the guidelines of the relevant international
expert societies, sentinel lymph node-biopsy (SLNB) is recommended as a diagnostic method of choice. The aim
of this study is to evaluate the value of the afore-mentioned algorithm and in the clinical context the reliability
and the associated morbidity of this procedure.
Methods: Between 2008 and 2015, 25 patients with invasive penile cancer and inconspicuous inguinal lymph
node status underwent SLNB after application of the radiotracer Tc-99m labelled nanocolloid. We recorded in a
prospective approach the reliability and the complication rate of the procedure. In addition, we evaluated the
results of an algorithm for SPECT/CT-data assessment of these patients.
Results: SLNB was carried out in 44 groins of 25 patients. In three patients, inguinal lymph node metastases were
detected via SLNB. In one patient, bilateral lymph node recurrence of the groins occurred after negative SLNB.
There was a false-negative rate of 4 % in relation to the number of patients (1/25), resp. 4.5 % in relation to the
number of groins (2/44). Morbidity was 4 % in relation to the number of patients (1/25), resp. 2.3 % in relation to
the number of groins (1/44). The results of computer-assisted assessment of SPECT/CT data for sentinel lymph
node (SLN)-diagnostics demonstrated high sensitivity of 88.8 % and specificity of 86.7 %.
Conclusions: SLNB is a very reliable method, associated with low morbidity. Computer-assisted assessment of
SPECT/CT data of the SLN-diagnostics shows high sensitivity and specificity. While it cannot replace the
assessment by medical experts, it can still provide substantial supplement and assistance.
Keywords: SPECT/CT, Computer-assisted assessment, Penile cancer, Sentinel lymph nodes, Lymph node biopsy,
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Background
Application of Tc-99m-labelled lymphogenic tracers for
pre- and intraoperative detection of sentinel lymph node
(SLN) is an internationally established standard procedure,
not only in malignant melanoma and breast cancer, but
also in penile cancer with an intermediate or higher de-
gree of differentiation and a non-palpable inguinal lymph
node status, and it is recommended in the guidelines of
international expert societies [1–5]. During the develop-
ment phase of this staging method, the Dutch workgroup
around Horenblas, but also other workgroups, reported
false negative rates of ca. 15 % [6, 7]. Data from a
meta-analysis by Neto et al. require a critical view [8].
These include studies examining the results of sentinel
lymph node-biopsy (SLNB) in patients with palpable in-
guinal lymph nodes. SLNB is not recommended by the
national and international expert society guidelines in
patients with palpable inguinal lymph nodes due to its
high unreliability [3].
But only in a few countries such as the United Kingdom
and the Netherlands SLNB in penile cancer is established as
a standard procedure. In other countries including Germany
this procedure is used neither widely nor regularly.
The reason for the lack of wide application in this en-
tity might also be found in the high methodical demands
of this method, which requires an experienced interdis-
ciplinary team, consisting of experts in nuclear medicine,
urologists and pathologists including the necessary ex-
pertise and equipment. Apart from the gamma probe
that urologists employ intraoperatively, hybrid devices
enabling both functional and morphological imaging
is used, primarily preoperatively, for modern lymph-
scintigraphical diagnostics.
The advantages of this combined imaging device over
conventional planar scintigraphy (used in the procedure to
date) lies in the improvement of diagnostics through co-
registration of the anatomical and functional images, and
thus better detection and more exact localization of the
findings in SLN diagnostics due to augmented image infor-
mation [9–15]. Fusion of both imaging methods helps to
improve anatomical allocation of the radio-labelled lymph
nodes enables improved preoperative localization and
operative planning. Furthermore, preoperative SLN im-
aging with single photon emission computed tomography/
computed tomography (SPECT/CT) is also beneficial
from a surgical point of view in various tumor entities:
on the one hand, selective SLNB has helped to decrease
postoperative morbidity after oncological interventions;
moreover, it offers clinically relevant information re-
garding optimal surgical access and the vicinity of im-
portant anatomical structures like vessels and nerves
[7, 21]. On the other hand, studies have also shown the
intraoperative advantages of exact preoperative imaging
via SPECT/CT in SLNB. Both for open surgery and
laparoscopic SLNB, studies have demonstrated signifi-
cantly higher numbers of intraoperatively identified
lymph nodes [22, 23]. Compared to intraoperative SLN
detection by a gamma probe alone, preoperative hybrid
imaging has helped to shorten the operation time of SLNB
significantly [24]. In consideration of the results collected
in the afore-mentioned, studies it becomes clear that pre-
cise and complete preoperative SLN diagnostics with
SPECT/CT is of high clinical relevance for pre- and intra-
operative SLN detection, in many tumor entities.
Hybrid imaging, not only in preoperative SLN-imaging,
generates much larger amounts of image data. Therefore,
a downside of hybrid imaging has to be seen in the large
amounts of generated image data, the interpretation and
assessment of which can be very time-consuming and
requires expertise both in nuclear medicine and in
radiology. Thanks to modern and potent information
technology (IT) systems, it is close at hand to use
specialized systems for helping the experts analyze and
assess these large amounts of digital images. In image-
related medical disciplines, this has prompted the evo-
lution of special image processing software, developed
to help the medical expert assess large amounts of
digital image data in less time to achieve better diag-
nostic results. The literature reports studies on software
applications and analyses of lung scintigraphy for embolism
diagnostics [16], and for automated assessment of fluor-
deoxyglucose positron-emission-computed-tomography/
computertomography (FDG-PET/CT)-examinations in
non-small-cell bronchial carcinoma [17]. Moreover,
programs for post processing in nuclear medical im-
aging are now commercially available. For example, pro-
grams for analysis of skeletal and myocardial perfusion
scintigraphy from EXINI Dignostics (Lund, Sweden); or
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computer-assisted processing of pre synaptic dopamin
uptake transporter-scintigraphy of the brain can be
performed via “Statistical Parametric Mapping” (SPM)-
programs in patients with Parkinson syndrome.
But to our knowledge, data for the application of
post-processing programs for SLN-diagnostics in pe-
nile cancer are not available in the literature yet. The
aim of this prospective study is for the first time to
evaluate a program for assessment of preoperative
SPECT/CT-imaging to detect radio-labelled sentinel
lymph nodes in this tumor entity, and to analyze the
reliability and morbidity of SLNB with a view to asses-
sing if the use of the described post-processing pro-
gram may influence the reliability and morbidity of
this procedure in our cohort.
Methods
Between 2008 and 2015, 25 patients with histologically
proven, invasive penile cancer and inconspicuous in-
guinal lymph node status underwent SLNB after applica-
tion of the radiotracer Tc-99m-labelled nanocolloid. For
all enrolled patients, we performed preoperative SPECT/
CT-scans. The applied tracer is a pure gamma emitter
with a half-life of 6 h and energy of 141 keV.
All enrolled patients additionally underwent a physi-
cal examination including palpatory assessment of the
lymph node status and ultrasound screening of the
inguinal region prior to surgery. Section images via
magnetic resonance imaging (MRI) and computer to-
mography (CT) of the pelvic region including the
groins were performed as a facultative measure.
Sentinel lymph nodes (SLN) are by definition the first
lymph nodes draining the primary tumor and are thus
the most likely to receive metastatic spreading first.
Lymphatic mapping allows surgeons to locate and excise
the sentinel node by preoperative scintigraphy imaging
and/or intraoperative identification using a gamma
probe. However, these SLN detection methods cannot
predict if the node harbours metastatic cells [18]. In our
study, we have considered the lymph node with the
highest tracer uptake to be the SLN of the first order,
which must be located in the typical region for meta-
static spread of this tumor entity (i. e. in the groins). All
other radio-labeled lymph nodes are SLN of the second
or higher orders, or so called echelon nodes. The soft-
ware identifies all “hot nodes” and offers a list of poten-
tially true and false findings (hot spots) in the order of
calculated probabilities. The probability value is derived
from both SPECT and CT indices to determine how
likely “true” or “false” the given hot spot is. Intraopera-
tively, the radioactive inguinal lymph nodes were identi-
fied by using a handheld gamma probe. No pelvic lymph
nodes were removed because only the groins are typical
SLN regions. Nuclear medical visualization of the SLN was
done following the so-called two-day protocol [19, 20]. On
the preoperative day, the patients underwent intrader-
mal, peritumoral injection of the radio tracer in local
anesthesia. We applied an overall activity of 150 MBq
Tc-99m-labelled nanocolloid. We performed lymphatic
drainage scintigraphies: either on the day of injecting
the radio nuclide at least one hour p. i., − or, in case of
lacking or retarded lymphatic drainage, on the morning
before the intervention. We acquired SPECT/CT scans
of the lower abdomen and pelvis including the inguinal
region by means of a twin head SPECT/CT-hybrid
camera (Siemens, Symbia T and Symbia Intevo). Acqui-
sition of SPECT scans was done using Low Energy High
Resolution (LEHR) -collimators in a 128 x 128 matrix,
90 views at 12 s acquisition intervals, in a continuous
mode and at a 180° detector configuration. Reconstruction
of SPECT data was done via Flash 3D-iterative reconstruc-
tion with eight iterations and 16 subsets and a Gaussian
filter of eight mm. CT data were acquired in a so-called
low-dose technique: tube voltage 130 kV, pitch factor 1.5,
reference-mAs 17, layer thickness 5 mm, collimation
2 x 4 mm. The functional imaging scans were fused
with co-registered CT scans (Fig. 1). Morphological
imaging enabled attenuation correction of the emis-
sion data as well as easier anatomical allocation of the
radio-marked lymph nodes. All images were saved in
the DICOM format.
Subsequent to imaging process, the SLN were identi-
fied and marked with a Co-57 pen as well as a felt-tip
pen on the skin surface. In addition, patent-blue was
injected directly preoperatively intradermally resp. peri-
tumorally. Intraoperative identification of the SLN was
thus possible both visually via the patent blue staining,
as well as by measuring radioactivity with the gamma
probe. Complete histopathological preparation of the
SLNs was done in 100 micrometer (μm) sections with
additional hematoxylin-eosin staining.
Computer-assisted assessment of SPECT/CT data
For evaluation of the computer-assisted assessment the
underlying SPECT/CT data sets of lymphatic drainage
scintigraphy of the enrolled patients were initially ana-
lyzed and consensually assessed by an expert in nuclear
medicine and a combined expert in radiology and nu-
clear medicine. Subsequently, the data sets were assessed
exclusively by the Software (InterView FUSION/Mediso)
to provide classification of each detected SPECT hot
spot individually. Finally, the computer-assessed findings
were corrected by the afore-mentioned experts. In each
of the mentioned analyses, the findings were classified
according to the respective side (left/right) and their
anatomical position as either inguinal or secondary
(parailiac and paraaortal) lymphatic drainage regions.
The results of the respective assessments were analyzed
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statistically; sensitivity, specificity, the false-positive rate
and the false-negative rate were calculated in a crosstab
with the respective algorithms. For software-based as-
sessment and experts (re-)assessment, we used the early
recordings of the images (1 h p. i.) if they showed radio-
active lymph nodes. Otherwise, the later acquired im-
ages, (17 h p. i.), were used for both the computer-based
analysis and the expert assessment, regardless of
whether radioactive lymph nodes could be visualized in
these images. Finally, we measured the time required for
the respective assessment modes, i. e. the experts assess-
ment alone and the software assessment plus the re-
quired expert correction time.
The workflow of this computer-assisted assessment
program consists chiefly of the following three steps:
1. Segmentation of SPECT data,
2. Segmentation of CT data,
3. Classification of results (hot nodes/lymph nodes)
Due to the initially different spatial resolutions of
SPECT (4 × 4 × 4 mm) and CT (1 × 1 × 5 mm) the re-
spective image lattice geometry were resampled into a
uniform voxel format of 1 × 1 × 1 mm to enable voxel
wise computer-assisted analysis. To this end, a cubic
thin plate (b-spline) interpolation was used both for
SPECT and for CT leading to increase of the smoothing
effect [21]. Nevertheless this known side-effect was an
acceptable trade-off in return to be able to perform
voxel wise analysis. For improvement of the interpret-
ability, the background noise of functional imaging was
removed from SPECT data by the means of appropriate
semi-quantitative threshold values (all values < 1 % of
the injected activity). Figure 2 shows a fused SPECT/CT
maximum-intensity-projection (MIP)-3D-image after ap-
plication of the tracer.
SPECT Segmentation
For definition for the findings (hot spots) in the SPECT
a moving 3 × 3 × 3 voxel mask was applied in order to
detect local maxima positions serving as seed point for
segmentation. A recursive region-growing algorithm was
used in all detected focus areas (hot spots). Employing
this region-growing process, every defined focus area
was compared with its 26 neighboring voxels in an itera-
tive process to achieve exact spatial allocation of the
findings and thus identification of the focus areas (hot
spots). If, in this process, a neighboring voxel was
smaller or equal to the actual voxel value, it was allo-
cated to the latter. If, however, there was an increase of
the value of the neighboring voxels, it was not included
in the give region. If a voxel met the region growing
Fig. 1 Preoperative visualization of sentinel lymph nodes via SPECT/CT: Evidence of so-called “hot spots” in the right inguinal region as well as in
the periphery of the tumor (application site)
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criteria but it was already the member of another already
segmented region, it was signed as common voxel. After
all hot spots were individually segmented these common
regions were deleted from the regions. In this way we
were able to ensure that no hot spot was lost or
absorbed by the neighboring voxels and that none of
them touched one another on the voxel level. Figure 3
shows a graphical representation of the SPECT segmen-
tation steps. As the segmentation approach searched for
local maxima in the smallest possible kernel in resampled
images, it was ensured that neighboring local maxima
voxels with at least one lower voxel value in between
could be identified as separate regions. Hence, the only
limitation of this approach was the spatial resolution of
the SPECT imaging technology. If neighboring hot spots
could not be distinguished in the original SPECT
image, i. e. if it showed no multiple, but only one local
maximum position, the program treated them as a
single larger hot spot.
CT Segmentation
In consideration of anatomical and physiological charac-
teristics, it is possible to define certain criteria for the
localization of lymph nodes, which qualify the findings
as either potentially true or definitely false. Lymph nodes
cannot be located extracorporally, in parenchymous or-
gans or in bones. SLNs consist of lymphatic tissue and
are embedded in fatty and connective tissue. Therefore,
the CT data were segmented according to their res-
pective tissue type, i. e. according to their density value
as Hounsfield units (HU) and classified as four different
types: air, fatty tissue, muscle and bone. For further statis-
tical analysis, we allocated the numbers 0–3 resp. colors
to these tissue types. As “bone” has no homogeneous mor-
phological structure, the bone region was mathematically
replaced by post-processed one generated by morpho-
logical closing operation [22]. Table 1 shows the resulting
criteria for segmentation of tissue types according to HU.
Figure 4 shows an axial CT image of the abdomen, on the
left-hand side as a representation the original image and
on the right-hand side of the segmented image. The rea-
son for this approach was that our CT images were low-
dose with a 5 mm transaxial resolution. Due to this,
lymphatic tissue inside true lymph node spots could not
be visualized by the applied CT imaging technology. Thus,
the CT voxel HU values inside the hot spots were no
useful features for the classification. Nevertheless, we
found that the direct vicinity of the hot spots was a
stable feature to determine the type of the surrounding
tissue, thus assisting the final classification of the hot
spots. Only those CT-data that were relevant for the
afore-mentioned segmentation and identification of hot
spots in the emission data were considered by the
algorithm. However, further information such as mor-
phological aspects or findings was not considered by
the program in any way.
Classification of findings (hot spots/lymph nodes)
We determined parameters for each hot spot of the
computer-assisted analysis for both imaging modalities
and classified these as “true” or “false” findings based on
the algorithm. For classification as a “true” finding and
thus “true” lymph node the finding (hot spot) had to ful-
fill all criteria regarding predefined SPECT and CT pa-
rameters. The program finally offered the medical
experts separate lists with “true” and “false” findings for
perusal and checking. The order of both lists was deter-
mined by the program based on probability of the results
being “true” or “false”. The individual probabilities were
Fig. 2 Preoperative 3D-MIP-Fusion imaging of pelvic SPECT/CT in a
patient prior to application of the program (above) and after application
of the method with elimination of the tumor region/application site
(below) as well unchanged visualization of the SLN (hot spots) in the
right inguinal region
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calculated based both on SPECT and CT [23]. These
computer-generated lists are presented in Fig. 5 as a seg-
ment from the program’s user surface as shown the
lower left screen. These lists with the “true” and “false”
findings are then separately evaluated and corrected by
the afore-mentioned experts and, in case that certain
findings are considered falsely “true” or “false” by the in-
dividual expert, they are moved to the respective other
list.
A false-negative finding of the program was defined as
a finding which was originally assigned to the list of
“false findings” by the program, but was later assigned to
the list of “true findings” by the experts. In analogy, a
false-positive result was defined in the reverse manner,
i. e. as a finding that was originally assigned to the list
of “true findings” by the program, but was later assigned
to the list of “false findings” by the experts. To this end,
we matched each individual finding in our evaluation
(n = 803), ensuring that both the number and the
localization of the findings listed in the respective data
analysis match. In addition, we matched our SLN diagnos-
tic data with the information from operation reports from
the Dept. of Urology and Pediatric Urology, and with the
Fig. 3 Schematic representation of hot spot detection and segmentation by SPECT in a 2D example. a Original image with two hot spots with
their respective local maxima (“A” and “B”). b Result of region growing from local maxima “A” (borders with dashed contour). Note that the
bottom of the smaller region is also absorbed as it met the region growing criteria. c Result of the region growing from local maxima “B”
(borders with dashed contour). Note that comon voxels were excluded from both regions. d Segmented regions (black contour)
Table 1 Segmentation of tissue types after HE
Classification/color HE min. HE max. Tissue type
0/black < (min.) - 200 Air
1/yellow - 200 - 20 Fat
2/red - 20 150 Muscle
3/white 150 > (max.) Bone
Fig. 4 Axial CT image of the abdomen: Left side of the image:
original scan/Right side of the image: segmented CT image with
staining of the different tissue types (air = black, fat = yellow,
muscle = red, and bone = white)
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histopathological findings from the Dept. of Pathology.
This matching led to surgical identification of the radio-
labelled lymph nodes, proven by the fact that histological
analysis detected lymphatic tissue in all samples. Each of
the resected SLN corresponded to our preoperatively de-
tected “true” findings (hot spots) according to the cor-
rected software list. The exact workflow of the program is
described by a similar workgroup around the authors of
this study [23].
Clinical aspects: reliability and morbidity
Each enrolled patient of this study received prophylactic
antibiotic therapy as a single shot application of cephalo-
sporin prior to surgery. Incisions were made for extirpation
of the lymph nodes, following the relaxed skin tension lines
at the location of the marks on the skin surface. In a first
step, those SLNs were resected that had preoperatively
been visualized by SPECTand could intraoperatively be de-
tected by the gamma probe. Subsequently we removed fur-
ther possible radioactive LNs which were not visualized in
preoperative images, but by the use of the gamma probe
only. Finally an exploration of the groins followed to check
for any blue-stained LNs without radioactive signal; in
addition supplementary intraoperative palpation of all
groins was carried out to check if suspect LNs remained.
All patients were provided with drains at the end of sur-
gery. The drains were left in place until the flow-rate was
equal or smaller than 20 ml per 24 h.
Fig. 5 Excerpt from the screen display of the software (InterView FUSION/Mediso) with axial CT scan of the abdomen. The hot spot marked with
a cross on the right inguinal region was identified as a “true” finding by the software and thus as a true SLN. On the lower left periphery of the
image you can find the lists of the “true” and “false” findings (red frame)
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All patients underwent follow-up examinations of in-
guinal lymph node via palpation and sonography in
three-monthly intervals in accordance with the Euro-
pean Association of Urology (EAU) guidelines. In case of
positive SLN with proven presence of malign cells, we
performed classical lymphadenectomy (LAE) of the af-
fected inguinal region, with the additional options of pel-
vine LAE and systematic cytotoxic therapy in a second
or third step. Morbidity and disease-free survival (DFS)
after SLNB were clinically evaluated during outpatient
follow-up visits.
The incidence of a false-negative result of the procedure
was defined as the occurrence of lymph node metastases
during follow-up examinations, despite histologically in-
conspicuous SLN-diagnostics.
Statistical analysis
Sensitivity, false-negative rate, specificity and false-positive
rate were evaluated statistically. We calculated the values
using a cross-table and the following formulas:
Sensitivity ¼ a= a þ cð Þ
Specificity ¼ d= b þ dð Þ
False−positive rate ¼ b= b þ dð Þ
False−negative rate ¼ c= a þ cð Þ
a = Number of true-positive findings; b =Number of false-
positive findings; c = Number of false-negative findings;
d = Number of true-negative findings.
Prior to the procedure, all patients were duly informed
about the details of the measures and gave their written
informed consent for this guideline-conform procedure.
In addition, the study was approved by the Ethics Com-
mittee of Kiel University (AK D 426/07).
Results
The median age of the 25 enrolled patients at the time
of primary diagnosis of the malignant disease was 60
(34–84) years. The details of the malignant disease,
tumor characteristics and the results of SLN diagnostics
are presented in Table 2.
Computer-assisted analysis of SPECT/CT data
The detailed results of the conventional consensual
evaluation by experts, of the software alone, and of the
software after correction by experts, including the re-
quired time for each, are presented for all 25 SPECT/CT
datasets in Table 3.
The conventional consensual evaluation of 25 SPECT/
CT data of lymphatic drainage scintigraphy by experts of
nuclear medicine resp. radiology and nuclear medicine
led to a total of 127 radio-labeled lymph nodes in 25 pa-
tients (Table 3: column 4, row 10).
The computer-based evaluation of all available data
showed a total of 803 findings (hot spots), of which 215
were identified as “true” findings and 588 as “false” findings
by the program (Table 3: column 5, rows 17, 10 and 14).
All radio-labelled lymph node findings detected in the
expert evaluation were also identified as findings (hot
spots) by the software. However, these were not always
correctly allocated to the list of “true” findings, thus ren-
dering amendments by the experts was necessary.
Thus, the findings solely generated by the software
were corrected by the medical experts. As expected, the
corrected evaluation of all data sets after analysis by the
software still led to a total of 803 findings (hot spots), of
which 143 were eventually classified as “true” findings
and 660 as “false” findings (Table 3: column 6, rows 17,
10 and 14).
Table 4 shows the analysis of results of all findings re-
garding both lymphatic drainage regions, including the
inguinal regions and the secondary drainage regions, in
a crosstab. Of the 215 findings labelled “true” according
to software analysis, 88 were assessed as “false-positive”
by the experts and were thus attributed to the list of
“false” findings. By reverse, of the findings labelled “false”
(588) by software analysis, 16 were assessed as “false-
negative” by the experts and thus moved to the list of
“true” findings. Thus, there was a need for correction in
104 out of 803 findings. This corresponds with an over-
all rate of false-positive or false-negative findings of
12.95 %. In consideration of both groups of findings,
both the “true” and the “false” findings in the original
computer assessment, a median of 3 (0–13) corrected
findings per dataset was calculated.
Considering the need for correction only in the group
of originally “true” findings, a median of 2 (0–12) findings
per dataset was calculated. In the group of the originally
“false” findings, the median of the need for correction was
0 (0–5) findings per dataset.
When considering the inguinal regions separately, in view
of the fact that it is only in the groins that radio-labelled
SLN are clinically relevant in this tumor entity, then the
need for correction was present in a total of 57 findings
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within this lymphatic drainage region. When considering
both groups of findings, both the “true” and the “false” find-
ings of the original software assessment, we calculated a
median of 2 (0–8) findings per dataset for the separately
considered inguinal regions that required correction.
Considering the need for correction in the separate
inguinal regions only in the group of originally “true”
findings, we found a median of 1 (0–7) finding per data-
set with a need for correction; in the originally “false”
findings we found a median of 0 (0–2) findings per data-
set with a need for correction.
Based on the calculated figures and results, we were
able to calculate the false-positive and false-negative
rates, and thus sensitivity and specificity in a crosstab
(Table 4).
The sensitivity is 88.8 % and the specificity is 86.7 %.
The false-positive rate amounts to 0.133 and the false-
negative rate to 0.112.
Table 3 Detailed representation of results in the different assessment modes
Column 1 2 3 4 5 6






2 Number (n) inguinal (“true”)
Lynph Nodes (LNs)
∑ 83 128 83
3 R/L 47/36 65/63 42/41
4 Median 3 5 3
5 Range 0–6 0–12 0–9
6 pelvic (“true”) LNs ∑ 44 87 60
7 R/L 27/17 51/36 39/21
8 Median 1 1 1
9 Range 0–8 0–13 0–11
10 all (“true”) LNs ∑ 127 215 143
11 R/L 74/53 116/99 81/62
12 Median 5 6 4
13 Range 0–13 1–19 0–15
14 all (“false”) LNs ∑ - 588 660
15 Median - 20 22
16 Range - 3–74 3–78
17 all (“true”) and (“false”)
LNs (findings)
∑ 127 803 803
18 Median 5 29 29
19 Range 0–13 6–80 6–80
20 Required assessment
time (min)
Average 14.6 0.91 4.4
21 Median 14.7 0.93 4.2
22 Range 12.3–17.7 0.7–1.0 2.3–7.9
Table 4 Crosstab of the assessment results of all (inguinal and secondary) LNs, software analysis vs. correction of computer assessment
by specialists (a1 = Number of true-positive findings; b1 = Number of false-positive findings; c1 = Number of false-negative finding;
d1 = Number of true-negative findings)
Correction of computer assessment by specialists
SLN proven SLN disproven Sum


























(a1 + b1 + c1 + d1)
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Table 5 shows the analysis of the results concerning
the finding of the inguinal lymphathic drainage regions
in a crosstab. However, not all cells of the crosstab can
be filled as the figures are not available due to the com-
puter analysis. Therefore we can only calculate the sensi-
tivity value and the false-negative rate for the inguinal
lymphathic drainage region.
For the inguinal lymphatic drainage region only sensi-
tivity is 92.8 % and in this context the false-negative rate
amounts to 0.072.
The mean time span needed for the different types of
assessments per patient is:
– 14.6 min for the conventional assessment by the
experts
– 0.9 min for the software assessment
– 4.4 min for the correction of the software results by
the experts.
Clinical aspects: reliability and morbidity
In 20 out of 25 patients the inguinal lymph node status
was non-palpable and thus inconspicuous on both sides.
In 5 further patients the inguinal lymph node status was
palpable and thus suspect only on one side, with non-
palpable lymph nodes on the other. Lymph node metasta-
ses were histologically proven in 3 out of these 5 palpable
i. e. suspect groins. In the remaining 2 suspect groins the
nodal status was histologically negative. One further pa-
tient showed a unilateral inguinal drainage of the tracer.
The last mentioned 6 groins were not evaluated in this
study as the expert society guidelines did not recommend
SLNB in these cases. Thus we included 44 non-palpable,
inconspicuous groins in the analysis. We removed a me-
dian number of 2 (1–5) lymph nodes per inguinal region
in the groins examined by SLNB in this study. In relation
to the included patients we removed a median number of
4 (1–13) lymph nodes per patient. All of the resected LNs
with a blue staining also showed a radioactive signal, but
not all of the radio-labelled inguinal nodes were stained.
In confirmation of the preoperative palpation status, no
conspicuous lymph nodes could be found during intraop-
erative palpation of the groins. In 3 patients lymph node
metastases were diagnosed after histological SLN analysis,
one per groin in each of these patients. In one patient, bi-
lateral inguinal lymph node recurrence was diagnosed
only four months after histologically negative SLNB. In
this patient the tumor- and resection status was initially
stated to be unclear by external experts after primary
tumor excision (pT1G1Rx) ex domo. To gain clarity on
the tumor- and resection stage, a re-resection of the pri-
mary tumor region was conducted in our Dept. of Urology
and Pediatric Urology. After histological processing, an in
sano resection (R0) with respect to the primary tumor was
proven. Palpation of the groins in this patient did not
show any suspect inguinal lymph nodes, so that we in-
cluded this patient in the study and conducted SLNB. In
the combined functional and morphological SPECT/CT
imaging, we had seen a radio-labelled inguinal lymph
node left, which was found to be histologically negative. In
the inguinal region on the right side no tracer-labelled
lymph node could be detected. Because of the fact that a
bilateral inguinal lymph node recurrence occurred in this
patient four months after SLNB we assume that the non-
visualization of the lymph node on the right inguinal side
was a consequence of a total tumor-related blockage. For
the left groin, this finding can be interpreted as a so-
called re-routing with visualization of a histologically
negative neo-SLN (Fig. 6). This patient eventually
underwent radical inguinal and pelvine LAE as well adju-
vant chemotherapy. The patient has since been tumor-free
during follow-up. For the other 39 groins with non-
palpable inguinal lymph nodes histological analysis of SLNB
led to a negative result. None of the 39 groins showed any
signs of recurrence during the follow-up examinations and
have remained tumor-free since SLNB. Thus these groins
have shown a mean resp. Median disease-free survival of 41
resp. 43.5 months (8–79 months). From these results we
calculated a false negative rate for SLNB of 4 % in relation
to the number of patient (1/25 patients) as well as 4.5 % in
relation to the number of examined groins (2/44 groins). In
Table 5 Crosstab of the assessment results of inguinal lymph nodes only, software analysis vs. correction of computer assessment
by specialists (a2 = Number of true-positive findings; b2 = Number of false-positive findings; c2 = Number of false-negative finding;
d2 = Number of true-negative findings)
Correction of computer assessment by specialists
SLN proven SLN disproven Sum


























(a2 + b2 + c2 + d2)
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one patient a surgery-related complication in form of
a prolonged inguinal lymphorrhea occurred in one
groin after SLNB; the latter ceased spontaneously dur-
ing Redon drainage. We calculated a morbidity rate
of 2.3 % per groin (1/44 groins) resp. 4 % per patient
(1/25 patients). One patient died during follow-up ca.
12 months after SLNB due to metastasized renal cell
carcinoma.
Based on the data presented in Table 6 the statistical
analysis per patient yields to a sensitivity of 75 % and a
specificity of 100 %. The false-positive rate amounts to
0 % and the false-negative rate to 25 %. The values per
groin yield to a sensitivity of 60 % and a specificity of
100 %. From this angle the false-positive rate is 0 % and
the false-negative rate 40 %.
Discussion
Computer-assisted analysis of SPECT/CT data
As mentioned in “Background”, several studies addressing
different malignant tumor entities have described the
advantages of SLN scintigraphy with multimodal 3-
dimensional SPECT/CT imaging for SLN diagnostics in
comparison to planar scintigraphy [9–15]. But also in
our study the performance of SPECT/CT SLN imaging
leads to a great amount of digital data which were post-
processed by a computer aided algorithm.
In our study, we calculated 88.8 % sensitivity and
86.7 % specificity based on the results of the SLN-
diagnostics assessment program in 25 analyzed datasets
from patients with penile cancer without palpable in-
guinal lymph nodes.
Fig. 6 Schematic representation of inguinal lymphatic drainage after tracer application. Right groin: Complete blockage of tracer flow. Tumor cells
(red) prevent drainage of the peritumorally applied tracer into the inguinal lymph nodes. Left groin: Rerouting of the tracer flow into the so-called
neo SLN. Tumor cells in the true SLN cause rerouting of lymphatic drainage and lead to new lymphatic pathways being opened. The tracer thus
accumulates in the histologically negative neo SLN
Table 6 Cross-table of the results of SLNB and follow-up (reference standard) and SLNB alone per patient
Results of SLNB and follow-up (reference standard)
Histo. positive Histo. negative Sum















all negative findings/c + d
22
(41)
Sum all true SLN/a + c
4
(5)
all false SLN/b + d
21
(39)
all findings/a + b + c + d
25
(44)
The results per groin are presented are presented in brackets
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When considering the individual inguinal regions,
which are the primary zones of lymphogenic dissemin-
ation of this tumor entity, separate analysis of the in-
guinal lymphatic drainage regions lead to a sensitivity
value of 92.8 %.
Compared to other imaging assessment programs, our
values for sensitivity and specificity are excellent. For ex-
ample, Sadik et al. [25] showed the potential of
computer-based assessment (EXINI bone) of nuclear
medical imaging for detection of bone metastases by
means of planar total bone scintigraphy. This study with
a cohort of 59 patients with breast or prostate cancer,
calculated a sensitivity of 90 % and a specificity of 89 %
for this assessment program [25]. These results are com-
parable to our figures. A further study by Sadik et al.
one year later showed that sensitivity of the assessing
medical expert alone could be increased from 78 to 88 %
by means of assistance by appropriate software. Regarding
specificity, however, the aid by a program achieved no
significant improvement [26]. Another study on hybrid
imaging evaluated computer-assisted assessment of FDG-
PET/CT data in 87 patients with suspected bronchial car-
cinoma. Sensitivity in this study was reported to be 86 %
and specificity 100 % [27]. Further studies evaluating
computer-assisted image assessment were performed for
diagnostics and analysis of myocardial perfusion scintig-
raphy. In 2008, Tägil et al. calculated an increase of sensi-
tivity from 81 % (without computer assistance) to 86 %
with computer-assisted analysis (EXINI heart) in 97 myo-
card scintigraphies. Especially inexperienced physicians
were able to improve their sensitivity rates with this pro-
gram. In addition, the differences between the assessment
of individual experts became smaller under application of
the program, thus helping to reduce interobserver vari-
ability [28].
Comparison of the median values of the expert-
diagnosed lymph nodes per patient with SPECT/CT
imaging (5 all “true” lymph nodes/3 inguinal lymph
nodes/1 secondary lymph node), with the “true” findings
of Software alone per SPECT/CT dataset (6 all “true”
findings/5 inguinal and 1 secondary lymph node) and
the corrected “true” findings of the analysis software
per SPECT/CT dataset (4 all corrected “true” findings/
3 inguinal and 1 secondary finding) showed that the
program in the uncorrected application suggests slightly
more “true” findings as radio-labelled SLN than the ex-
perts alone or the corrected software. In practice, this
could be interpreted as a higher rate of supposedly
false-positive findings. The program is not fully cap-
able on its own to reiterate the expert results, making
corrections by experts necessary. Correct and accurate
tracer application, which should be strictly peritu-
moral and intradermal, seems to have a special im-
pact on the number of results (hot spots) offered by
the program. If this measure is not carried out in an
optimal way, the list of “false” findings suggested by
the program will be increased, requiring more expert
corrections. Categorization as “false” findings was, how-
ever, correctly accomplished in the majority of program-
based data analyses.
We also evaluated the time required by this form of
computer-aided data assessment; similar to the results
by Baker et al. 2007, who measured a mean additional
required time of 3 min 38 s for correction of computer
results in a study on colorectal adenoid diagnostics via
CT, the correction time required in our study was
4.4 min on average. The main factor contributing to the
time consumption was, according to Baker et al., the
high rate of false-positive results. Perusal and correction
of these often cost more time than the confirmation of
true-positive results. Correction of false-negative hot
spots barely made an impact [29]. A study by Taylor et
al. attempted to validate whether an increase of the
false-positive rate might influence the diagnosis of the
assessing expert. This was clearly disproven. Further-
more the increase of expert assessment time also be-
came evident here, as a high rate of false-positive
findings had to be checked [30]. In the current study, we
were able to correct both the clearly false-positive and
false-negative results of the automated assessment
quickly and without any remaining doubts. Despite this,
complete and careful checking of all diagnosed findings
(hot spots) was necessary. This contributed, if only little,
to the time expenditure, which, however, remained mod-
erate in comparison with other studies; the time re-
quired for computer-aided image analysis per dataset
with and without correction was still less than that re-
quired by conventional expert assessment, which was
average 14.6 min per patient. The non-corrected,
computer-assessed dataset is available after an average of
55 s, depending on computing power and speed of data
input by the user. Expert validation of the suggested
findings resp. lymph nodes requires 4.4 min on average
according to our measurement described above. Regular
application and routine could lead to further reduction
of the time expenditure. It has to be noted, however, that
the here applied automated assessment did not include
any further morphological aspects of CT resp. classical
assessment of the CT image. Supplementing functional
imaging with morphological information from CT in
hybrid imaging, offers the advantage of detecting unex-
pected, i. e. incidental clinical findings. In a study analys-
ing the frequency of incidental findings during routine
examinations, 567 out of 1426 patients (39.8 %) were di-
agnosed with at least one incidental finding. 55 % of
these findings could be attributed to thorax CT. Six of
the 567 patients experienced a clinical advantage of the
incidental finding as it enabled therapy at an early stage
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resp. adaptation of the therapeutic regimen. Three pa-
tients, however, were unnecessarily burden through
false-positive findings in this study [31]. A limiting fac-
tor of the here applied assessment program lies in the
fact that it does not consider the CT-based secondary
findings for SLN detection. In our patient collective,
however, conventional evaluation by our medical ex-
perts did not show any case with an indication of a
tumor-suspect incidental finding that might have re-
quired further investigation.
Clinical aspects: reliability and morbidity
In our study, we were able to show excellent reliability
of SLNB after application of the afore-described proced-
ure with radio-labelled tracers for visualization of SLN,
with a false negative rate of only 4.5 % per groin resp.
4 % per patient. Like us, the British workgroup around
Lam et al. adopted the two-day protocol developed and
first evaluated by the Horenblas workgroup. Lam and
coworkers report a false negative rate of 5 % (in rela-
tion to the groins) resp. 6 % (in relation to the patients)
in a cohort of 264 patients. The faulty procedures
occurred chiefly during the implementation phase of
the method [33].
In comparison with the results of Lam et al. [33] or
Kroon et al. [34] who report rates of 28 respectively
22 % of histologically positive lymph nodes under em-
ployment of SLNB, our rate of metastatic disease is
much lower (12 %). The reason might be that the pa-
tients enrolled in the study of Lam et al. had a signifi-
cantly higher risk of metastatic disease, as can be seen in
the lower number of T1-tumours (42 %) compared to
our study (68 %). More importantly, the study of Lam et
al. included a higher rate of G3-tumours (53 %). In our
study the G3-tumour rate is only 20 %. A further reason
is that the study by Kroon et al. included only patients
with T2- and T3-tumours, while T1-tumours were not
taken into account, in contrast to our study. This could
explain why our values for sensitivity appear low while
the false-negative rate is high. There are no data in the
literature on the false negative rates of the classic in-
guinal staging LAE.
Limitations of SLNB
Tumor cells can lead to obstruction resp. occlusion of
the lymphatic drainage pathways, either by complete
blockage or by rerouting of the radio tracer (Fig. 6) [6, 35].
Impediment of the transit resp. the drainage of the
injected radioactive tracer can lead to restraints of SLNB.
The risk of a relevant modification of lymphatic and thus
tracer drainage depends on the metastatic load in the
lymphatic pathways and in the lymph nodes. The risk of
metastases in patients with palpable lymph nodes is at
50 % much higher than in those with non-palpable
inguinal lymph nodes (25 %). For this reason, SLNB is not
recommended by the national and international expert so-
cieties in patients with palpable inguinal lymph nodes, as
mentioned before [3].
The validity of clinical groin palpation is influenced
both by the physical constitution of the patient and the
level of skill and experience of the examiner. In the case
of the patients from our study who developed bilateral
lymph node recurrence 4 months after histologically
negative SLNB, the assessment of inguinal lymph node
status was impeded by obesity. Obesity is capable of veil-
ing otherwise palpable and potentially tumor-infested
lymph nodes, thus wrongly leading to the conclusion
that the patient is eligible for SLNB. For minimization of
misjudgment we have introduced obligatory preoperative
sonography of the groins in all of our patients, as a sup-
plement to clinical palpation.
A further possible source of errors for the application
of this procedure is associated with the two-stage ap-
proach of SLNB after surgical removal of primary tumor.
While Graafland et al. [36] report uniform results in 40
cases of a metachronously performed SLNB, we believe
that surgery-related modifications of the tracer drainage,
e. g. through scar formation or edema, might be a pos-
sible cause for the false-negative SLNB in patient of this
study.
Computer-aided assessment - clinical consequences
Based on our study results, which included only one
false-negative result of SLNB, we cannot answer the
question whether the software in combination with
fused SPECT/CT data is capable of reducing the number
of false negative findings, and whether the patients can
expect a diagnostic and prognostic advantage regarding
morbidity and especially mortality. In the case of a false-
negative SLNB, which showed a bilateral lymph node re-
currence four months after histologically inconspicuous
SLNB, application of the software had failed to visualize
a hotspot due to complete tracer blockage in the right
inguinal region, and on the left side a so-called re-
routing with visualization of a neo-SLN occurred (Fig. 6),
which was also visualized in the tracer image of
computer-assessment, but turned out to be histologically
negative. Additional imaging with FDG-PET/CT is cap-
able of improving preoperative diagnostics with a par-
ticular view to cases with palpable lymph nodes or a
doubtful lymph node status.
Despite consensus reading by experienced physicians,
the expert analysis alone (n = 127) missed a few hot
spots when compared against the total number of
lymphatic drainage regions detected and offered in lists
of true and false findings by the program (Fig. 5).
Consensus analysis by experienced physicians alone
yielded 127 hot nodes in all lymphatic drainage regions.
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After expert correction of the program results, the num-
ber of the detected hot spots in all lymphatic regions in-
creased to 143 (Table 3, line 10). Thus 16 hot spots were
missed when comparing both types of analyses; the
missed hot spots were exclusively located in the pelvic
lymphatic regions. In view of the high sensitivity of the
software, we assume that the experts were able to make
their decision regarding the higher number of findings
suggested by the program with greater confidence. But
the number of hot nodes detected in both analyses was
the same (n = 83, Table 3, line 2), when focusing on the
interesting inguinal regions only. Therefore the surgical
procedures were not influenced significantly by the re-
sults of the computer analysis, as the LN surgery, as part
of the SLNB procedure, was strictly limited to the
groins. Despite the fact that the images and their inter-
pretation were available prior to surgery for surgical
planning, intraoperative detection of radioactive lymph
nodes using a gamma probe lead to nearly the same
number of detected radioactive lymph nodes in our 25
patients (83 vs. 88/94.3 %). The crucial aspect is that all
preoperatively detected hot nodes in both types of pre-
operative iamge evaluation were found intraoperatively
by using the probe. Intraoperative use of the sensitive
gamma probe also lead to the detection of 5 additional
radioactive lymph nodes in our 44 investigated groins.
We assume that the direct identification of the radio-
active inguinal lymph nodes using the handheld probe at
a negligible distance and the absence of tissue attenu-
ation during surgery, which is present in the preopera-
tive scintigraphical imaging, lead to a higher sensitivity
of the intraoperative probe, resulting in a higher number
of detected lymph nodes (88). Moreover, the time span
between pre- and intraoperative SLN detection may have
led to a more extensive tracer flow in the lymphatic
pathways and may also be responsible for the higher
number of intraoperatively detected inguinal lymph
nodes in this study.
Application of computer-aided assessment in larger
patient collectives, and possibly also in other tumor en-
tities, will have to show whether the software can help
to further reduce the low recurrence rates, based on the
fact that computer-aided assessment tends to indicate a
higher number of potential metastatic lymph nodes for
radio-guided biopsy.
Currently, the concept behind the software is to dis-
tinguish between “true” and “false” findings exclusively
on the basis of pre-defined parameters in the program.
Correction of individual findings is both necessary and pos-
sible. Potential improvements are currently not processed
by the program and thus cannot be applied in the suc-
ceeding datasets, in other words, the program cannot
learn from the expert corrections. A self-improving pro-
gram would be capable of continuously minimizing the
number both of false-positive and false-negative results
based on supervised “Machine-Learning” approaches.
In this context, so-called “artificial neural networks”
(ANN) play a role as they may be able to remedy
current limitations.
There are data on the impact of ANN on existing
assessment software, regarding the reduction of false-
positive findings. Thus a program for detection of pul-
monary coin lesions was able to reduce the rate of
false-positive findings by more than 68 % after an ANN
algorithm had been established, without impairing the
sensitivity of the procedure [32].
Implementation of a similar algorithm would be ad-
vantageous for the assessment program examined here,
and will be in focus during further development of the
system.
At the current stage, the program is not yet capable of
performing fully automatic and correct assessment of
the SPECT/CT datasets (especially with regard to further
assessment of the CT-data as described in “Methods”).
False-positive and false-negative findings continue to re-
quire expert correction, ideally by experts with combined
knowledge in nuclear medicine and radiology. While the
assessment software evaluated here cannot replace expert
assessment after preoperative SLN diagnostics in penile
cancer, it can supplement and support the expertise even
of highly specialized physicians. Moreover, the program is
an apt tool for supporting and educating doctors in
training and can help them to double-check their own
assessment of findings.
Conclusions
SLNB with SLN-labelling by means of Tc-99m nanocol-
loids in penile cancer is a valuable diagnostic method
with low morbidity. It offers a high degree of reliability,
especially when it is performed during resection of the
primary tumor. The here evaluated computer-assisted
assessment of SPECT/CT data for SLN diagnostics
shows high sensitivity and specificity in this tumor en-
tity. While the program cannot replace expert assess-
ment, it is able to provide substantial support and relief
for the medical experts. Especially less experienced doc-
tors and specialists in training are able to profit from
this program during their learning curve. However, the
methodical and logistic demands placed to an interdis-
ciplinary team remain high despite (semi-) automated
data assessment. This method should only be applied in
specialized centers and by interdisciplinary teams in this
rare tumor entity.
Acknowledgements
We thank Mrs. Almut Kalz for proof-reading and editing the manuscript, as
well as Mr. Felix Prell and Mr. Bernhard Egeler for the design of graphical
representations.
Lützen et al. Cancer Imaging  (2016) 16:29 Page 14 of 16
Funding
There is no funding in connection with this study.
Availability of data and materials
The datasets during and/or analysed during the current study available from
the corresponding author on reasonable request.
Authors’ contributions
UL: Protocol development, Manuscript writing. CMN: Statistical analysis,
Manuscript editing. MM Acquisition of data. YZ: Statistical analysis. MJ:
Statistical analysis. RB: Acquisition of data. LP: Development of program. NZ:
Development of program. AA: contributed to conception. KPJ: contributed to
conception. MZ: Data analysis, Manuscript editing. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no conflict of interest or competing
interests in connection with the manuscript.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in
accordance with the ethical standards of the institutional and/or national
research committee and with the 1964 Helsinki declaration and its later
amendments or comparable ethical standards. Prior to the procedure, all
patients were duly informed about the details of the measures and gave
their written informed consent for this guideline-conform procedure. The
study was approved by the Ethics Committee of the Christian-Albrechts-
University of Kiel (Az. D426/07).
Author details
1Department of Nuclear medicine, Molecular Imaging Diagnostics and
Therapy, University Hospital Schleswig Holstein, Campus Kiel, Feldstr. 21
(Haus 50), 24105 Kiel, Germany. 2Department of Urology and Pediatric
Urology, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
3Department of Radiotherapy, University Hospital Schleswig Holstein,
Campus Kiel, Kiel, Germany. 4Division of Nuclear Medicine, Medical University
of Vienna, Vienna, Austria. 5Mediso Ltd., Budapest, Hungary.
Received: 18 May 2016 Accepted: 21 August 2016
References
1. DGN-Handlungsempfehlung 031–033 - 031-033l_S1_Wächter_
Lymphknoten_Diagnostik_2014-10.pdf [Internet]. Available from: http://
www.awmf.org/uploads/tx_szleitlinien/031-033l_S1_W%C3%A4chter_
Lymphknoten_Diagnostik_2014-10.pdf. Accessed 24 Aug 2016.
2. S3 Leitlinie Melanom-Kurzfassung - 032-024k_S3_Melanom_Diagnostik_
Therapie_Nachsorge_2013-02.pdf [Internet]. Available from: http://www.
awmf.org/uploads/tx_szleitlinien/032-024k_S3_Melanom_Diagnostik_
Therapie_Nachsorge_2013-02.pdf. Accessed date 24 Aug 2016.
3. Hakenberg OW, Compérat EM, Minhas S, Necchi A, Protzel C, Watkin N,
et al. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2015;67:
142–50.
4. Vogt H, Schmidt M, Bares R, Brenner W, Grünwald F, Kopp J, et al.
Procedure guideline for sentinel lymph node diagnosis. Nukl Nucl Med.
2010;49:167–72. quiz N19.
5. Poppel HV, Watkin NA, Osanto S, Moonen L, Horwich A, Kataja V, et al.
Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 2013;24:vi115–24.
6. Kroon BK, Horenblas S, Estourgie SH, Lont AP, Valdés Olmos RA, Nieweg OE.
How to avoid false-negative dynamic sentinel node procedures in penile
carcinoma. J Urol. 2004;171:2191–4.
7. Kirrander P, Andrén O, Windahl T. Dynamic sentinel node biopsy in penile
cancer: initial experiences at a Swedish referral centre. BJU Int. 2013;111:
E48–53.
8. Neto AS, Tobias-Machado M, Ficarra V, Wroclawski ML, Amarante RDM,
Pompeo ACL, et al. Dynamic sentinel node biopsy for inguinal lymph node
staging in patients with penile cancer: a systematic review and cumulative
analysis of the literature. Ann Surg Oncol. 2011;18:2026–34.
9. van der Ploeg IMC, Olmos RAV, Nieweg OE, Rutgers EJT, Kroon BBR,
Hoefnagel CA. The Additional Value of SPECT/CT in Lymphatic Mapping in
Breast Cancer and Melanoma. J Nucl Med. 2007;48:1756–60.
10. Schillaci O, Danieli R, Manni C, Simonetti G. Is SPECT/CT with a hybrid
camera useful to improve scintigraphic imaging interpretation? Nucl Med
Commun. 2004;25:705–10.
11. von Forstner C. Der Einsatz von SPECT/CT bei der
Wächterlymphknotendiagnostik. Nukl. 2011;34:59–65.
12. Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M, et al.
Fusion of SPECT and multidetector CT images for accurate localization of
pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med
Technol. 2005;33:78–82.
13. Vermeeren L, Valdés Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV,
et al. Value of SPECT/CT for detection and anatomic localization of sentinel
lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate
carcinoma. J Nucl Med Off Publ Soc Nucl Med. 2009;50:865–70.
14. Dorn R, Holl G. SLN-Diagnostik bei Tumoren des Beckens, Nuklearmediziner.
2006;29(2):116–22.
15. Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al.
Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT
system. J Nucl Med Off Publ Soc Nucl Med. 2003;44:1413–20.
16. Evander E, Holst H, Järund A, Ohlsson M, Wollmer P, Aström K, et al. Role of
ventilation scintigraphy in diagnosis of acute pulmonary embolism: an
evaluation using artificial neural networks. Eur J Nucl Med Mol Imaging.
2003;30:961–5.
17. Hahn S, Heusner T, Zhou X, Hamami M, Bockisch A, Forsting M, et al.
Automatische Läsionserkennung und Auswertung in der PET/CT: Evaluation
einer neuen Software am Beispiel des nicht-kleinzelligen Bronchialkarzinoms
(NSCLC) [Internet]. Fortschr Röntgenstr. 2009. Available from: https://www.
thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1221553.
Accessed date 24 Aug 2016.
18. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E, et al.
Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol
Imaging. 2007;34:2154–9.
19. Leijte JAP, Hughes B, Graafland NM, Kroon BK, Olmos RAV, Nieweg OE, et al.
Two-center evaluation of dynamic sentinel node biopsy for squamous cell
carcinoma of the penis. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:3325–9.
20. Fuchs J, Hamann MF, Schulenburg F, Knüpfer S, Osmonov D, Lützen U, et al.
Sentinel lymph node biopsy for penile carcinoma : Assessment of reliability.
Urol Ausg A. 2013;52:1447–50.
21. Lehmann TM, Gönner C, Spitzer K. Addendum: B-spline interpolation in
medical image processing. IEEE Trans Med Imaging. 2001;20:660–5.
22. Jamil N, Sembok TMT, Bakar ZA. Noise removal and enhancement of binary
images using morphological operations. Int Symp Inf Technol 2008 ITSim.
2008;2008:1–6.
23. Papp L, Zsoter N, Loh C, Ole B, Egeler B, Garai I, et al. Automated lymph
node detection and classification on breast and prostate cancer SPECT-CT
images. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol
Soc Annu Conf. 2011;2011:3431–4.
24. Vidal-Sicart S, Brouwer OR, Mathéron HM, Bing Tan I, Valdés-Olmos RA.
Sentinel node identification with a portable gamma camera in a case
without visualization on conventional lymphoscintigraphy and SPECT/CT.
Rev Esp Med Nucl E Imagen Mol. 2013;32:203–4.
25. Sadik M, Hamadeh I, Nordblom P, Suurkula M, Höglund P, Ohlsson M, et al.
Computer-assisted interpretation of planar whole-body bone scans. J Nucl
Med Off Publ Soc Nucl Med. 2008;49:1958–65.
26. Sadik M, Suurkula M, Höglund P, Järund A, Edenbrandt L. Improved
classifications of planar whole-body bone scans using a computer-assisted
diagnosis system: a multicenter, multiple-reader, multiple-case study. J Nucl
Med Off Publ Soc Nucl Med. 2009;50:368–75.
27. Gutte H, Jakobsson D, Olofsson F, Ohlsson M, Valind S, Loft A, et al.
Automated interpretation of PET/CT images in patients with lung cancer.
Nucl Med Commun. 2007;28:79–84.
28. Tägil K, Bondouy M, Chaborel JP, Djaballah W, Franken PR, Grandpierre S,
et al. A decision support system improves the interpretation of myocardial
perfusion imaging. Eur J Nucl Med Mol Imaging. 2008;35:1602–7.
29. Baker ME, Bogoni L, Obuchowski NA, Dass C, Kendzierski RM, Remer EM, et al.
Computer-aided detection of colorectal polyps: can it improve sensitivity of
less-experienced readers? Preliminary findings. Radiology. 2007;245:140–9.
Lützen et al. Cancer Imaging  (2016) 16:29 Page 15 of 16
30. Taylor SA, Greenhalgh R, Ilangovan R, Tam E, Sahni VA, Burling D, et al. CT
colonography and computer-aided detection: effect of false-positive results
on reader specificity and reading efficiency in a low-prevalence screening
population. Radiology. 2008;247:133–40.
31. Orme NM, Fletcher JG, Siddiki HA, Harmsen WS, O’Byrne MM, Port JD, et al.
Incidental findings in imaging research: evaluating incidence, benefit, and
burden. Arch Intern Med. 2010;170:1525–32.
32. Suzuki K, Shiraishi J, Abe H, MacMahon H, Doi K. False-positive reduction in
computer-aided diagnostic scheme for detecting nodules in chest
radiographs by means of massive training artificial neural network. Acad
Radiol. 2005;12:191–201.
33. Lam W, Alnajjar HM, La-Touche S, Perry M, Sharma D, Corbishley C, et al.
Dynamic sentinel lymph node biopsy in patients with invasive squamous
cell carcinoma of the penis: a prospective study of the long-term
outcome of 500 inguinal basins assessed at a single institution. Eur Urol.
2013;63:657–63.
34. Kroon BK, Horenblas S, Meinhardt W, van der Poel HG, Bex A, van Tinteren H,
et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10
years experience. Eur Urol. 2005;47:601–6. discussion 606.
35. Leijte JAP, van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, Horenblas S.
Visualization of tumor blockage and rerouting of lymphatic drainage in
penile cancer patients by use of SPECT/CT. J Nucl Med Off Publ Soc Nucl
Med. 2009;50:364–7.
36. Graafland NM, Valdés Olmos RA, Meinhardt W, Bex A, van der Poel HG,
van Boven HH, et al. Nodal staging in penile carcinoma by dynamic sentinel
node biopsy after previous therapeutic primary tumour resection. Eur Urol.
2010;58:748–51.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lützen et al. Cancer Imaging  (2016) 16:29 Page 16 of 16
